Cargando…

Objective assessment of tumor regression in post-neoadjuvant therapy resections for pancreatic ductal adenocarcinoma: comparison of multiple tumor regression grading systems

Neoadjuvant therapy is increasingly used to control local tumor spread and micrometastasis of pancreatic ductal adenocarcinoma (PDAC). Pathology assessments of treatment effects might predict patient outcomes after surgery. However, there are conflicting reports regarding the reproducibility and pro...

Descripción completa

Detalles Bibliográficos
Autores principales:	Matsuda, Yoko, Ohkubo, Satoshi, Nakano-Narusawa, Yuko, Fukumura, Yuki, Hirabayashi, Kenichi, Yamaguchi, Hiroshi, Sahara, Yatsuka, Kawanishi, Aya, Takahashi, Shinichiro, Arai, Tomio, Kojima, Motohiro, Mino-Kenudson, Mari
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7588464/ https://www.ncbi.nlm.nih.gov/pubmed/33106543 http://dx.doi.org/10.1038/s41598-020-74067-z

Ejemplares similares

Adequate tissue sampling for the assessment of pathological tumor regression in pancreatic cancer
por: Yokohira, Masanao, et al.
Publicado: (2021)

Area of residual tumor (ART) can predict prognosis after post neoadjuvant therapy resection for pancreatic ductal adenocarcinoma
por: Okubo, Satoshi, et al.
Publicado: (2019)

Area of residual tumor is a robust prognostic marker for patients with rectal cancer undergoing preoperative therapy
por: Sakuyama, Naoki, et al.
Publicado: (2018)

Tumor Regression Grading of Gastrointestinal Carcinomas after Neoadjuvant Treatment
por: Thies, Svenja, et al.
Publicado: (2013)

Pattern of tumor regression after neoadjuvant chemoimmunotherapy for esophageal squamous cell carcinoma
por: Li, Bin, et al.
Publicado: (2023)

New tumor regression grade for rectal cancer after neoadjuvant therapy and radical surgery
por: Li, Jun, et al.
Publicado: (2015)

Tumor Lymphocyte Infiltration Is Correlated with a Favorable Tumor Regression Grade after Neoadjuvant Treatment for Esophageal Adenocarcinoma
por: Haddad, Riad, et al.
Publicado: (2022)

Tumor regression in rectal cancer after intensified neoadjuvant chemoradiation: a morphometric and clinicopathological study
por: Prall, Friedrich, et al.
Publicado: (2015)

Correlation between tumor regression grade and rectal volume in neoadjuvant concurrent chemoradiotherapy for rectal cancer
por: Lee, Hong Seok, et al.
Publicado: (2016)

Examination of Tumor Regression Grading Systems in Breast Cancer Patients Who Received Neoadjuvant Therapy
por: Sejben, Anita, et al.
Publicado: (2020)

Comparison of tumor regression grading systems for locally advanced gastric adenocarcinoma after neoadjuvant chemotherapy
por: Liu, Zi-Ning, et al.
Publicado: (2021)

Prognostic significance of tumor regression grade in esophageal squamous cell carcinoma after neoadjuvant chemoradiation
por: Zhang, Chi, et al.
Publicado: (2023)

Histological tumor necrosis in pancreatic cancer after neoadjuvant therapy
por: Kudo, Masashi, et al.
Publicado: (2022)

Significance of tumor spread through air spaces (STAS) in lung cancer from the pathologist perspective
por: Mino-Kenudson, Mari
Publicado: (2020)

Revisiting the role of T cells in tumor regression
por: Bercovici, Nadège, et al.
Publicado: (2012)

Spontaneous Regression of Endobronchial Carcinoid Tumor
por: Venkatram, Sindhaghatta, et al.
Publicado: (2017)

Multiparametric MRI-based radiomics analysis for the prediction of breast tumor regression patterns after neoadjuvant chemotherapy
por: Zhuang, Xiaosheng, et al.
Publicado: (2020)

Relevant issues in tumor regression grading of histopathological response to neoadjuvant treatment in adenocarcinomas of the esophagus and gastroesophageal junction
por: Klevebro, F, et al.
Publicado: (2020)

CA724 Predicts Tumor Regression Grade in Locally Advanced Gastric Cancer Patients with Neoadjuvant Chemotherapy
por: Tong, Yilin, et al.
Publicado: (2021)

Prognostic Value of Tumor Regression Grading in Patients Treated With Neoadjuvant Chemotherapy Plus Surgery for Gastric Cancer
por: Xie, Jian-Wei, et al.
Publicado: (2021)

Evaluation of tumor regression by neoadjuvant chemotherapy regimens for esophageal adenocarcinoma: a systematic review and meta-analysis
por: Chidambaram, Swathikan, et al.
Publicado: (2022)

Pathological tumor regression grade of metastatic tumors in lymph node predicts prognosis in esophageal cancer patients
por: Kadota, Tomohiro, et al.
Publicado: (2018)

Tumor regression grade combined with lymph node status in esophageal squamous cell carcinoma after neoadjuvant chemoradiotherapy
por: Yun, Jae Kwang, et al.
Publicado: (2022)

Development of a method for digital assessment of tumor regression grade in patients with rectal cancer following neoadjuvant therapy
por: Jepsen, Dea Natalie Munch, et al.
Publicado: (2022)

DOES NEOADJUVANT CHEMORADIOTHERAPY FOR ESOPHAGEAL AND GASTROESOPHAGEAL JUNCTION CANCER PATIENTS AFFECT POSTOPERATIVE OUTCOMES? A STUDY USING THE BECKER TUMOR REGRESSION GRADE SYSTEM AND LYMPH NODE REGRESSION
por: do Rosário, Maria Inês Vaz, et al.
Publicado: (2023)

A case of rectal tumor in which the shape altered with regression in short period
por: Nakamura, Fumihiko, et al.
Publicado: (2013)

Studies of Regression in a Transplantable Tumor in Mice
por: Bunting, Henry
Publicado: (1941)

Histological tumor response assessment in colorectal liver metastases after neoadjuvant chemotherapy: impact of the variation in tumor regression grading and peritumoral lymphocytic infiltration
por: Cai, Yibo, et al.
Publicado: (2019)

High Expression of EphA4 Predicted Lesser Degree of Tumor Regression after Neoadjuvant Chemoradiotherapy in Rectal Cancer
por: Lin, Ching-Yih, et al.
Publicado: (2017)

Tumor Regression Grading Assessment in Locally Advanced Pancreatic Cancer After Neoadjuvant FOLFIRINOX: Interobserver Agreement and Prognostic Implications
por: Cacciato Insilla, Andrea, et al.
Publicado: (2020)

A clinical nomogram for predicting tumor regression grade in esophageal squamous-cell carcinoma treated with immune neoadjuvant immunotherapy
por: Yu, Yongkui, et al.
Publicado: (2022)

CT-Based Radiomics Showing Generalization to Predict Tumor Regression Grade for Advanced Gastric Cancer Treated With Neoadjuvant Chemotherapy
por: Chen, Yong, et al.
Publicado: (2022)

Can patients with good tumor regression grading after neoadjuvant chemoradiotherapy be exempted from lateral lymph node dissection?
por: Liu, Xianwei, et al.
Publicado: (2022)

Response Prediction after Neoadjuvant Chemotherapy for Colon Cancer Using CT Tumor Regression Grade: A Preliminary Study
Publicado: (2023)

Forecasting Individual Patients’ Best Time for Surgery in Colon-Rectal Cancer by Tumor Regression during and after Neoadjuvant Radiochemotherapy
por: Martorana, Emanuele, et al.
Publicado: (2023)

Linear Tumor Regression of Rectal Cancer in Daily MRI during Preoperative Chemoradiotherapy: An Insight of Tumor Regression Velocity for Personalized Cancer Therapy
por: Sung, Soo-Yoon, et al.
Publicado: (2022)

A Case of Adult Pancreatoblastoma With Novel APC Mutation and Genetic Heterogeneity
por: Suemitsu, Yamato, et al.
Publicado: (2021)

Spontaneous Regression of a Carcinoid Tumor following Pregnancy
por: Sewpaul, A., et al.
Publicado: (2014)

The Effect of Interleukin 36 Gene Therapy in the Regression of Tumor
por: Solahaye-Kahnamouii, Shiva, et al.
Publicado: (2014)

Molecular Signatures of Regression of the Canine Transmissible Venereal Tumor
por: Frampton, Dan, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_tat5qqkupfpbucv7889ep5ht0e